KEQU
Kewaunee Scientific Corporation38.49
+0.19+0.5%
Dec 16, 4:00:02 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
No earnings call transcript available
Key Stats
Market Cap
110.33MP/E (TTM)
9.77Basic EPS (TTM)
3.94Dividend Yield
0%Recent Filings
8-K
Q3 sales up 3.3%, intl surges
Kewaunee Scientific posted Q3 FY2026 sales of $69.4M, up 3.3% from prior year, with pre-tax earnings rising 25.8% to $1.6M despite softer domestic volumes. International sales surged 21.4% to $18.4M, fueled by India, offsetting U.S. construction slowdowns. Backlog fell to $183.2M. Nu Aire integration bolsters resilience.
8-K
Q3 earnings date set
Kewaunee Scientific announced on February 25, 2026, its Q3 fiscal 2026 earnings release for March 11 after market close, available on kewaunee.com. The filing highlights its recent Nu Aire acquisition, adding biological safety cabinets and lab products to bolster the portfolio. Realizing acquisition benefits remains uncertain.
10-Q
Q2 FY2026 results
Kewaunee Scientific surged to $70.1M net sales in Q2 FY2026 ended October 31, 2025, up 47% y/y from $47.8M, while six-month sales hit $141.2M, up 47% y/y, fueled by the November 2024 Nu Aire acquisition for $53.0M (cash/seller notes), which added $19.4M revenue and recognized $12.5M goodwill plus $18.6M intangibles (customer relationships over 10 years). Gross margin slipped to 28.1% from 29.2% y/y amid integration and lower volumes, yet operating profit held at $4.1M and diluted EPS landed at $0.82 on 2,990K shares, reconciling cleanly. Domestic sales (>78% of total) drove growth; international rose 31% y/y on project deliveries. Cash fell to $12.6M with $1.5M OCF minus $2.3M capex, supported by $20M revolver availability and no covenant issues, though seller notes were repaid post-quarter. Volatility in lab project timelines persists.
8-K
Sales soar 47%, earnings slip
Kewaunee Scientific blasted Q2 FY2026 sales to $70.1M, up 46.8% year-over-year, fueled by 51.7% Domestic growth and Nu Aire's strong debut post its November 1, 2024 close. Pre-tax earnings dipped 12.2% to $3.5M amid lab construction volatility, yet backlog hit $192.9M. Nu Aire offsets legacy swings.
8-K
Repays $23M seller notes early
Kewaunee Scientific repaid its $23.0 million seller notes from the November 2024 Nu Aire acquisition in full on December 4, 2025, ahead of the November 2027 maturity. Funded partly by a $10.0 million PNC term loan and revolver draws, this refinances 8% notes. Debt load drops. Interest expense shrinks.
IPO
Website
Employees
Sector
Industry
BSET
Bassett Furniture Industries, I
17.42+0.14
FGI
FGI Industries Ltd.
6.12+0.74
FLXS
Flexsteel Industries, Inc.
42.40-0.11
HNI
HNI Corporation
41.05-0.50
HOFT
Hooker Furnishings Corporation
10.91+0.40
LEG
Leggett & Platt, Incorporated
11.44-0.21
SCS
Steelcase Inc.
16.14+0.02
SN
SharkNinja, Inc.
113.87+0.25
VIRC
Virco Manufacturing Corporation
6.61+0.06
WHR
Whirlpool Corporation
75.58-1.68